News

FendX Announces Grant of Japanese Patent to Protect REPELWRAP(TM) Film

Japanese Patent Represents FendX's 4th Patent IssuedOakville, Ontario--(Newsfile Corp. - October 29, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB:…

1 year ago

Pioneering Insights: ERG, Lotus, and GMG Unveil Study on the potential impact of GLP-1 Agonists and Cognitive Health in Diabetes and Obesity

NEW PROVIDENCE, N.J., Oct. 29, 2024 /PRNewswire/ -- Evolution Research Group (ERG) and Lotus, portfolio companies of Emerge HoldCo, LLC, in…

1 year ago

Linus Health to Demonstrate How Digital Health Powers Innovation at Clinical Trials on Alzheimer’s Disease (CTAD)

Leaders to deliver four poster presentations showing how its digital health platform lowers investigator burden, enables precision recruitment, and delivers…

1 year ago

The Tianqiao & Chrissy Chen Institute’s OMNE Framework for Long-term AI Memory Claims Top Spot on GAIA Leaderboard

REDWOOD CITY, Calif., Oct. 28, 2024 /PRNewswire/ -- Drawing on their deep knowledge of the brain and memory, the Tianqiao…

1 year ago

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29,…

1 year ago

AiRISTA Awarded Asset Tracking & Management Solutions agreement with Premier, Inc.

TIMONIUM, Md., Oct. 29, 2024 /PRNewswire/ -- AiRISTA, a global leader in real time location services (RTLS), has been awarded…

1 year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

RANCHO CUCAMONGA, CA / ACCESSWIRE / October 29, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…

1 year ago

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases

VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased…

1 year ago

IRLAB Reports Continued Progress Ahead of the Mesdopetam Phase III Program

GOTHENBURG, SWEDEN / ACCESSWIRE / October 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

1 year ago

TTEC Recognized as a Leader in Everest Group’s 2024 CXM Services PEAK Matrix® Assessment for the Americas for the Fourth Consecutive Year

The company also named a Major Contender in APAC, EMEA regions for third year in a row DENVER, Oct. 28,…

1 year ago